Latest News
AFT Pharmaceuticals latest news
Stay updated with the latest advancements and breakthroughs in the pharmaceutical industry.
May 1, 2024
AFT Licenses Maxigesic® IV in Brazil
We are delighted to announce our partnership with Brazil’s Halex Istar, and to be exclusively responsible for distributing its Maxigesic IV in Brazi…
April 24, 2024
AFT, Massey Ventures, Gilles McIndoe to develop scar treatment
AFT collaborate with Massey Ventures and Gilles McIndoe to begin the development of a topical treatment for keloid and hypertrophic scarring….
March 5, 2024
AFT makes further progress in international markets
AFT Pharmaceuticals provides an update on recent progress it has made in international markets….
February 19, 2024
AFT updates operating profit guidance to $23m to $25m
AFT Pharmaceuticals today announces an update to guidance for the financial year to the end of March 2024 (FY24)….
February 8, 2024
MAXIGESIC<sup>®</sup> SPONSORS THE ONE NZ WARRIORS
AFT Pharmaceuticals announces Maxigesic® is the new Official Pain Relief Partner of the One New Zealand Warriors for the 2024 and 2025 NRL seasons….
February 7, 2024
Maxigesic IV launched in the United States
AFT Pharmaceuticals announces Maxigesic IV®, the patented intravenous form of its family of pain relief medicines, has today been launched in the US …
January 19, 2024
AFT further broadens R&D pipeline with new product candidate for Vulva Lichen Sclerosus
AFT Pharmaceuticals announces it has entered into a further partnership with one of its long-standing research and development partners, Belgium’s H…
January 17, 2024
AFT poised to accelerate momentum in 2024
As the new year commences, AFT Pharmaceuticals is looking forward to building upon the significant progress made during 2023. Last year we moved on fr…
January 8, 2024
AFT broadens R&D pipeline with new product candidate in Burning Mouth Syndrome
AFT Pharmaceuticals today announces that it has entered into a partnership with one of its research and development partners, Belgium’s Hyloris Phar…
November 24, 2023
AFT Pharma reports growth and global expansion
FINANCIAL RESULTS FOR THE SIX MONTHS TO 30 SEPTEMBER 2023…
October 18, 2023
AFT welcomes US FDA approval for sale of Maxigesic IV<sup>®</sup>
AFT Pharmaceuticals announces the US FDA has approved Maxigesic IV®, the intravenous form of its patented pain relief medicine, for sale in the US, w…
October 10, 2023
AFT Pharmaceuticals to announce half year interim results
AFT Pharmaceuticals announced today that it intends to release on Thursday November 23 2023 its half year interim results for the period ended Septemb…
October 3, 2023
AFT appoints Andrew Lane as independent director
AFT Pharmaceuticals today announces the appointment of Andrew Lane as an independent non-executive director….
October 3, 2023
Retirement of Jon Lamb
Independent director Jon Lamb today retired from the board following his announcement at the ASM. …
August 29, 2023
AFT Orphan Pharmaceuticals judgment
AFT Pharmaceuticals advises of the release yesterday evening by the High Court at Auckland of its judgment upholding in part claims by PBL Solutions L…
August 10, 2023
Retirement of Jon Lamb Announcement
AFT Pharmaceuticals (NZX.AFT, ASX.AFP) independent director Jon Lamb has announced his intention to retire as a director of the company, following the…
August 10, 2023
AFT Pharmaceuticals 2023 Annual Meeting
Annual Meeting Overview…
June 30, 2023
Notice of Annual Meeting of Shareholders 2023
<strong>June 30th 2023</strong> Notice is hereby given that the Annual Meeting of shareholders of AFT Pharmaceuticals Limited (AFT or t…
May 23, 2023
Financial Results 2023: AFT declares maiden dividend; record revenue
Financial Results for the 12 Months to 31st of March 2023…
May 4, 2023
AFT Pharmaceuticals to announce full year results on Monday May 22 2023
AFT Pharmaceuticals (NZX: AFT, ASX: AFP) announced today that it intends to release on Monday May 22 2023 its full year results for the year ended Mar…
May 4, 2023
US FDA sets PDUFA date for Maxigesic IV®
AFT Pharmaceuticals today announces the US Food and Drug Administration has set 17 October 2023 as the date by which it expects to respond to AFT’s …
April 19, 2023
AFT submits Maxigesic IV® packaging data to the US FDA
AFT Pharmaceuticals announces it has submitted to the US Food and Drug Administration (FDA) data the regulator requested, as it considers registration…
April 11, 2023
AFT gains first product registration in China for Crystawash Extend and extends Maxigesic IV licensing
As a result of these launches and recent sales AFT will enter the new financial year with Maxigesic sold in 61 countries in various dose forms, 15 mor…
March 14, 2023
Maxigesic Rapid® tablets gain US FDA approval
AFT Pharmaceuticals (NZX.AFT, ASX.AFP) today announces the US Food and Drug Administration has approved a rapid release tablet form of Maxigesic for t…
February 2, 2023
AFT to develop antibiotic eye drop
AFT Pharmaceuticals to develop antibiotic eye drop…
January 9, 2023
2023 New Year letter to investors
AFT Pharmaceuticals releases New Year letter to shareholders….
November 24, 2022
AFT extends growth investment as sales surge
AFT PHARMACEUTICALS LTD FINANCIAL RESULTS FOR THE SIX MONTHS TO 30 SEPTEMBER 2022…
October 11, 2022
AFT Pharmaceuticals to announce half year interim results on Thursday November 24 2022
AFT Pharmaceuticals announces the analysis of its study examining its medicine Pascomer as a topical treatment for facial angiofibromas (FA) associate…
July 28, 2022
AFT Completes Pascomer Clinical Study and Takes Back Rights in North America
AFT Pharmaceuticals announces the analysis of its study examining its medicine Pascomer as a topical treatment for facial angiofibromas (FA) associate…
July 22, 2022
Dr Doug Wilson to step down from AFT Board
AFT Pharmaceuticals today announces that Dr Doug Wilson will step down from its Board of Directors …
July 7, 2022
AFT and RooLife launch OTC medicines online in China
AFT Pharmaceuticals and RooLife Group today announce they have launched a range of AFT’s over the counter (OTC) pharmaceuticals through their store …
April 7, 2022
AFT Sponsors APP Conference 2022 with Crystawash Extend
AFT Pharmaceuticals participate in the Australian Pharmacy Professional (APP) Conference and Trade Exhibition in May 2021….
February 24, 2022
AFT Pharmaceuticals partners with Farmaforce
Farmaforce, an award-winning contract sales organisation offering innovative solutions to the Australian pharmaceutical industry, today confirmed its …
February 15, 2022
AFT launches preservative-free antibacterial eye drop Ocuzo
AFT Pharmaceuticals has opened a new front in its eye drop portfolio, with the introduction of a preservative-free product called Ocuzo for bacterial …
August 2, 2021
New clinical study shows Novaliq NovaTears<sup>®</sup> +Omega-3 eye drops is significantly effective treatment for dry eye disease.
NovaTears®+Omega-3, an innovative dry eye treatment in-licensed and distributed in Australia and New Zealand by AFT Pharmaceuticals, is a significant…
July 14, 2021
Maxigesic<sup>®</sup> Oral Liquid gets first regulatory approval
Maxigesic Oral Liquid – a non-opioid analgesic developed for children – achieves first approval in Europe to set up the first global launch and a pa…
June 9, 2021
AFT at APP 2021
AFT Pharmaceuticals participate in the Australian Pharmacy Professional (APP) Conference and Trade Exhibition in May 2021….
May 5, 2021
AFT extends Maxigesic<sup>®</sup> IV license in South America
AFT Pharmaceuticals (NZX.AFT, ASX.AFP) today announces it has licensed Maxigesic IV into Colombia, Peru, Chile, Ecuador, Bolivia, and Uruguay, extendi…
April 30, 2021
AFT licenses Maxigesic<sup>®</sup> IV in the US
AFT Pharmaceuticals announces it has signed an exclusive License and Distribution Agreement with Hikma Pharmaceuticals USA (“Hikma”) for the comme…
April 2, 2021
关于AFT制药
AFT制药的承诺是致力于创新，开发、许可和销售范围广泛的产品，以帮助改善人们的健康。…
April 2, 2021
About AFT Pharmaceuticals.
With a commitment to innovation, AFT Pharmaceuticals develops, licenses and sells a wide range of products to help improve the health and wellbeing of…
March 17, 2021
AFT licenses Pascomer for Europe
AFT Pharmaceuticals (NZX.AFT, ASX.AFP) today announces it has signed a new commercialisation and development agreement for its orphan drug Pascomer®…
March 17, 2021
Browse latest news
We develop, license, and sell pharmaceutical products in Australasia and around the world. Check out our latest news….
March 5, 2021
Maxigesic<sup>®</sup> IV licensed in eight new European markets
AFT Pharmaceuticals (NZX.AFT, ASX.AFP) today announces it has signed an exclusive Maxigesic® IV licensing agreement for eight new European markets….
February 17, 2021
创新产品
了解更多产品信息…
February 17, 2021
Our range of innovative products
Learn more about our range of products….
January 13, 2021
AFT confirms demonstration of 24-hour efficacy for Crystawash extend hand sanitiser
AFT Pharmaceuticals (NZX.AFT, ASX.AFP) today announces independent laboratories have found that its new Crystawash Extend Hand Sanitiser…
January 13, 2021
AFT builds North American momentum
Diversified pharmaceutical company appoints new north American-based director and launches Maxigesic® in Canada….
November 19, 2020
Management financial discussion and analysis for the half year to 30 September 2020
AFT Pharmaceuticals (NZX; AFT, ASX; AFP) today announces continued growth in revenue and normalised earnings as it benefits from growth across its por…
November 19, 2020
Financial results for half year ended 30 September 2020
AFT Pharmaceuticals (NZX; AFT, ASX; AFP) today announces continued growth in revenue and normalised earnings as it benefits from growth across its por…
November 18, 2020
AFT opening European office, signs new partners for maxigesic iv and oral range
AFT Pharmaceuticals (NZX.AFT, ASX.AFP) announces the establishment of a new subsidiary in Ireland…
November 9, 2020
AFT welcomes us fda complete response letter
AFT Pharmaceuticals (NZX.AFT, ASX.AFP) today announces it has received a US Food and Drug Administration (FDA) complete response letter (CRL)….
November 5, 2020
AFT appoints Anita Baldauf as a director
AFT Pharmaceuticals (NZX; AFT, ASX; AFP) has today appointed Anita Baldauf as a non-executive director….
November 4, 2020
AFT and Setek sign supply agreement
Agreement covers pharmaceutical-grade medicinal cannabis ingredients for products initially targeted for Australia and New Zealand…
November 3, 2020
Maxigesic IV® distribution deals signed in UK and Hong Kong
AFT Pharmaceuticals (NZX.AFT, ASX.AFP) has signed exclusive Maxigesic IV® distribution and supply agreements for the UK and Hong Kong, with the compa…
October 24, 2020
We’re big on 'out-of-the-box' thinking
<strong>We’re big on ‘out-of-the-box’ thinking as innovation truly lies at the heart of our business. Innovation in pharmaceuticals can ta…
October 23, 2020
Helping to improve lives
Ensuring more people around the globe have access to quality healthcare is an integral part of our ethos. <!–more–> With the support of lo…
October 23, 2020
Eyes4Everest: providing relief at the top of the world
Eyes4Everest is a charity that delivers eyecare to Himalayan communities. <!–more–> It was founded in 2013 by Sydney optometrist, Shaun Ch…
October 23, 2020
AusViet: bringing hope and health to disadvantaged people in Australia and Vietnam
AFT Pharmaceuticals was approached by Dr Nguyen Nguyen, a representative of the AusViet Charity Foundation. This charity is a ‘rolling medical commu…
October 22, 2020
Kiwi Health Flagship Store Launches in China on Tmall Global
ASX-listed RooLife (ASX:RLG) and ASX and NZX-listed AFT Pharmaceuticals (ASX:AFP, NZX:AFT) have officially launched the New Zealand branded online hea…
October 14, 2020
AFT Pharmaceuticals to announce half year interim results on Thursday November 19 2020
AFT Pharmaceuticals (NZX: AFT, ASX: AFP) announced today that it intends to release on Thursday November 19 2020 its half year interim results for the…
October 11, 2020
加入我们的团队
我们一直在寻找有才华的人，请访问下面的职业网站并了解我们目前提供的职业。<!–more–> Our people define us….
October 11, 2020
Join our team
We’re always looking for talented people, please have a look at the careers we currently have available by visiting our profile on the below Careers…
September 13, 2020
Kiwis Thinking About Health
Kiwis Thinking About Health is an initiative from AFT Pharmaceuticals that’s designed to help New Zealanders live a healthier life. <img src=…
September 8, 2020
Aussies Thinking About Health
Aussies Thinking About Health is an initiative from AFT Pharmaceuticals that’s designed to help Australians live a healthier life. <img src=…
August 24, 2020
Notice of Adjourned Annual Meeting of Shareholders 2020
Notice is hereby given that the adjourned Annual Meeting of shareholders of AFT Pharmaceuticals Limited (AFT or the Company) will be convened and held…
August 12, 2020
Urgent Adjournment of 2020 Annual Meeting
AFT Pharmaceuticals Limited (NZX:AFT/ASX:AFP) (AFT) advises that the Annual Meeting of shareholders of AFT scheduled for 10.30am (NZ time) today will …
July 30, 2020
Maxigesic IV® licensed in six new European nations
AFT Pharmaceuticals (NZX.AFT, ASX.AFP) has signed an exclusive Maxigesic IV® licensing and supply agreement for Bulgaria, Cyprus, the Czech Republic,…
July 29, 2020
New Zealand codeine restrictions set for November
AFT Pharmaceuticals (NZX:AFT, ASX:AFT) today welcomes Medsafe's announcement that all codeine and codeine-containing medicines will become prescr…
July 15, 2020
Notice of Annual Meeting of Shareholders 2020
Notice is hereby given that the Annual Meeting of shareholders of AFT Pharmaceuticals Limited (*AFT or the Company*) will be held at the Milford Cruis…
July 13, 2020
RooLife & AFT launch Online New Zealand Health Store in China
RooLife partners with ASX & NZX-listed AFT Pharmaceuticals (ASX:AFP, NZX:AFT) to deliver New Zealand branded online health & pharmacy store in…
July 1, 2020
AFT Pharmaceuticals Share Purchase Plan Oversubscribed
AFT Pharmaceuticals Limited (NZX:AFT/ASX:AFP) (AFT) is pleased to announce that its NZ$2 million share purchase plan (SPP) has closed oversubscribed. …
June 23, 2020
Nathan Hukill resigns from AFT'S Board
AFT Pharmaceuticals (NZX; AFT, ASX; AFP) today announces Nathan Hukill, president of the company's former major shareholder CRG, has resigned as …
June 15, 2020
AFT Pharmaceuticals announces opening of Share Purchase Plan
AFT Pharmaceuticals Limited (NZX:AFT/ASX:AFP) (AFT) is pleased to announce the opening of its NZ$2 million non-underwritten share purchase plan (SPP)….
June 11, 2020
AFT Pharmaceuticals announces successful completion of Placement
AFT Pharmaceuticals Limited (NZX:AFT/ASX:AFP) (AFT) is pleased to announce the successful completion of its NZ$73.8 million Placement (Placement), com…
June 10, 2020
AFT Pharmaceuticals announces capital raising to support liquidity and optimise capital structure
AFT Pharmaceuticals (NZX:AFT, ASX:AFP) (AFT, the Company), Atkinson Family Trust (AF Trust) and CRG today announce a capital raising to increase liqui…
June 5, 2020
Dispute with PBL Solutions Limited
AFT Pharmaceuticals Limited [NZX: AFT; ASX: AFP] advises that British Virgin Islands incorporated PBL Solutions Limited, the 35% shareholder in AFT�…
June 5, 2020
Annual Meeting and Closing Date for Director Nominations
AFT Pharmaceuticals Limited (NZX: AFT, ASX: AFP) (AFT) announces that its Annual Meeting of Shareholders is to be held at 10:30am (NZT) on Wednesday 1…
June 4, 2020
AFT secures Maxigesic IV® distribution in four Western European countries and reports Australasian market share gains in COVID-19 medicines
AFT Pharmaceuticals (NZX.AFT; ASX.AFP) today announces it has signed an exclusive distribution agreement with Austria's Ever Valinject (Ever) for…
May 20, 2020
AFT Pharmaceuticals breaks through $100 million revenue and posts record earnings
Highlights…
May 5, 2020
AFT Pharmaceuticals to announce full year results on Wednesday May 20 2020
AFT Pharmaceuticals (NZX: AFT, ASX: AFP) announced today that it intends to release on Wednesday May 20 2020 its full year results for the year ended …
March 23, 2020
AFT finalises refinancing and gives trading update
AFT Pharmaceuticals (NZX; AFT, ASX; AFP) today announces it has concluded an agreement with the Bank of New Zealand (BNZ) to refinance its current six…
February 27, 2020
AFT on track to refinance CRG team loan facility
AFT Pharmaceuticals (NZX; AFT, ASX; AFP) today announces that its six-year term loan facility from CRG maturing on 31 March 2020 is on track to be ref…
February 17, 2020
AFT licenses Maxigesic® IV in 21 new countries across CIS and Central America
AFT Pharmaceuticals (NZX; AFT, ASX; AFP) today announces it has licensed its Maxigesic® intravenous medicine (Maxigesic® IV) in 21 new countries acr…
January 28, 2020
AFT notes Maxigesic® sales estimates in new market research
AFT Pharmaceuticals (NZX; AFT, ASX; AFP) notes the publication of new market research that estimates the potential for AFT's patented medicine Ma…
December 11, 2019
AFT secures Maxigesic® IV distribution in Indonesia
AFT Pharmaceuticals (NZX; AFT, ASX; AFP) has signed an exclusive distribution agreement for the registration and commercialisation of Maxigesic IV® i…
December 6, 2019
AFT welcomes new codeine medicine restrictions
AFT Pharmaceuticals (NZX; AFT, ASX; AFP) today welcomes Medsafe's decision to classify all medicines containing codeine as prescription medicines…
November 27, 2019
Maxigesic to launch in Canada in 2020
AFT Pharmaceuticals (NZX.AFT, ASX.AFP) and Canadian speciality pharmaceutical company Biosyent Pharma Inc., today announce they have concluded an excl…
November 21, 2019
Financial Results For Half Year Ended 30 September 2019
*AFT earnings rise in line with guidance*…
November 18, 2019
AFT signs agreements to new markets worth more than US $1 billion
AFT Pharmaceuticals (NZX; AFT, ASX; AFP) today announces it has signed licensing agreements for its Maxigesic pain relief medication in Germany, Pakis…
November 4, 2019
AFT to book one-off non-cash gain on Pascomer assets
AFT Pharmaceuticals (NZX.AFT, ASX.AFP) announces it expects to book a one-off non-cash gain of $9.8 million following its previously-announced acquisi…
October 17, 2019
AFT Pharmaceuticals to announce half year results on Thursday November 21 2019
*AFT Pharmaceuticals to announce half year results on Thursday November 21 2019 *…
October 8, 2019
AFT and SETEK sign medicinal cannabis MoU
Market and Media Release 8 October 2019…
July 24, 2019
AFT Pharmaceuticals' achieves first registration of it's patented painkiller Maxigesic IV® in the pivotal Australian market
AFT Pharmaceuticals (AFT') today announces it has successfully registered the intravenous form of its successful Maxigesic' pain relief …
July 22, 2019
AFT Pharma Reaches Licensing Agreement for Pascomer in North America
*AFT Pharma Reaches Licensing Agreement for Pascomer® in North America *…
July 22, 2019
Notice of Annual Meeting of Shareholders 2019
Notice is hereby given that the Annual Meeting of shareholders of AFT Pharmaceuticals Limited (AFT or the Company) will be held at the Milford Cruisin…
July 1, 2019
AFT Pharmaceuticals Grabs #1 Top Seller Spot in Australian Eye Lubricant Market
MAXIGESIC® brand also retains #1 position in paracetamol/ibuprofen analgesic category….
June 21, 2019
AFT Pharmaceuticals' completes first deal in South America
*AFT signs Maxigesic® Licensing Agreement with Barcelona-based Galenicum Vitae S.L.U for Colombia, Peru and* Chile….
May 22, 2019
AFT Pharmaceuticals poised for strong earnings growth
*AUDITED FINANCIAL RESULTS FOR THE YEAR TO 31 MARCH 2019*…
May 22, 2019
AFT Pharmaceuticals establishes new borrowing facilities
AFT Pharmaceuticals (AFT) today announces it has established a NZ$15 million interim banking facility with the BNZ, enabling the company to commence r…
May 6, 2019
Announcement for FY19 Full Year Results
*AFT Pharmaceuticals to announce full year results on Wednesday May 22 2019*…
April 23, 2019
Clarification
AFT Pharmaceuticals notes that the Sunday Star Times interviewed AFT's founder and CEO Dr Hartley Atkinson for an article which appeared in the S…
April 12, 2019
AFT Pharmaceuticals' completes new deals for Maxigesic® in Mexico, Switzerland and Cyprus
AFT Pharmaceuticals' completes another 3 deals: Painkiller Maxigesic IV® is now licensed in Mexico together with Maxigesic® tablets in Switzerl…
January 31, 2019
Atenolol-AFT – NOW AVAILABLE
We are pleased to advise that Atenolol-AFT (atenolol 50 mg/10 mL) oral liquid 300 mL is now back in stock in both Australia and New Zealand….
September 26, 2018
Atenolol-AFT Update
We currently have a stock shortage of Atenolol-AFT (atenolol 50 mg/10 mL) oral liquid 300 mL in both Australia and New Zealand. The only product curre…
September 25, 2018
AFT Wins Ventura Supplier of the Year Award 2018
Innovative approach Consistency of stock supply/in stock position Engagement in promotions Over and above mind-set…
September 10, 2018
Pharmacy Assistant of the Year Award's 2018
AFT Pharmaceuticals is the very proud sponsor of the Pharmacy Assistant of the Year award and is delighted to support the Pharmacy Guild of Australia …
August 20, 2018
AFT provides support to AusViet Charity
AFT was approached by Dr Nguyen Nguyen, the WA Representative on behalf of the AusViet Charity Foundation (see logo below) This foundation isa non-pro…
June 1, 2018
Amcal Maxigesic $20,000 Promotion Winners!
Thanks to all those who entered the Maxigesic promotion in TerryWhite Chemmart stores to win a share of $20,000! Congratulations to our 20 winners lis…
May 31, 2018
TerryWhite Chemmart Maxigesic $20,000 Promotion Winners!
Thanks to all those who entered the Maxigesic promotion in TerryWhite Chemmart stores to win a share of $20,000! Congratulations to our 20 winners lis…
May 18, 2018
APP 2018 Competition
Thank you for visiting the AFT Pharmaceuticals stand at APP 2018 it was great to see you!…
March 19, 2018
Maxigesic Hits No. 1 In Key Australian Painkiller Market
The codeine-free painkiller Maxigesic is now the largest selling Paracetamol-Ibuprofen combination painkiller in Australian pharmacies….
March 5, 2018
ANZLF 2018
Earlier this week Hartley Atkinson, Managing Director of AFT Pharmaceuticals Ltd was proudly invited to attend The Australian New Zealand Leadership F…
January 19, 2018
Prescription-only codeine medicines in New Zealand welcomed
Yesterday the Medicines Classification Committee announced its recommendation that all codeine combination medicines, both analgesics and those used f…
January 19, 2018
AFT Pharmaceuticals' painkiller Maxigesic now licensed in first North American market, Mexico, taking licensed countries to 125
27-Dec-17…
October 20, 2017
Positive result from large US clinical trial for Maxigesic IV (Intravenous)
AFT Pharmaceuticals (AFT) has today announced the results of the major Phase 3 clinical trial for the intravenous (IV) form of its Maxigesic painkille…
September 1, 2017
AFT Pharmaceuticals celebrates 20 years of success
Twenty years ago this week, husband and wife Dr Hartley Atkinson and Marree Atkinson, started AFT Pharmaceuticals (AFT) in a room off their home garag…
May 22, 2017
AFT Pharmaceutical's painkiller Maxigesic now licensed in France, the world's second largest paracetamol and ibuprofen tablet market
AFT Pharmaceuticals (AFT') has extended its existing agreements to add a French pharmaceutical company to out-license the product line of its p…
May 19, 2017
Further European approval puts Maxigesic on path to become leading global paracetamol-ibuprofen painkiller
Chief Executive of AFT Pharmaceuticals, Dr Hartley Atkinson, says that having regulatory approval for these 9 additional countries will open up signif…
May 12, 2017
Maxigesic on track to access the large United States painkiller market
AFT Pharmaceuticals has been officially notified that the US Food and Drug Administration (FDA) has accepted its application to register its painkille…
March 22, 2017
AFT Pharmaceuticals In-Licenses NovaTears® in Australia and New Zealand
AFT Pharmaceuticals (AFT) has completed a licensing agreement with Novaliq, a German specialty pharmaceutical company, to distribute NovaTears® in Au…
January 25, 2017
New Maxigesic agreement for AFT Pharmaceuticals with Leading Nordic Consumer Health Company in Sweden, Norway, Finland, Denmark and Iceland
AFT Pharmaceuticals ('AFT') has licensed the product line of its patented combination painkiller, Maxigesic, in the Nordic region to Weifa A…
January 9, 2017
New agreement for AFT Pharmaceuticals with Leading European Pharma
AFT Pharmaceuticals (AFT') has executed an alliance agreement with privately-owned pharmaceutical company, Angelini, to license the product lin…
December 20, 2016
TGA decision will boost Maxigesic sales in Australia
*TGA decision will boost Maxigesic sales in Australia*…
December 7, 2016
AFT hits target to register NasoSURF with the FDA in the United States
AFT Pharmaceuticals (AFT) has today announced to investors the completion of a significant milestone in the development of its patented drug deliver…
May 13, 2016
Maxigesic Now Licensed in 109 Countries
New agreement for AFT Pharmaceuticals means Maxigesic is now licensed in 109 countries…
May 13, 2016
AFT Pharmaceuticals Strengthens Asian Operations
AFT Pharmaceuticals (AFT) is continuing to build its business operations in South East Asia by moving to the appointment of a Business Manager based i…
April 19, 2016
Win a chance to be a Maxigesic Millionaire winner named
Congratulations to the winner of our Maxigesic 'win a million' draw Lewis Williams from Priceline Pharmacy, Craigieburn. Lewis has won the c…
March 23, 2016
Maxigesic to carry Gold Cross logo of the Pharmacy Guild of Australia
Maxigesic to carry Gold Cross logo of the Pharmacy Guild of Australia…
March 4, 2016
AFT Pharmaceuticals Reaches Agreement for Maxigesic Licensing in 69 Additional Countries
AFT Pharmaceuticals (AFT') has reached agreement with privately-owned Swiss headquartered multinational pharmaceutical company, Acino Pharma AG…
January 12, 2016
New medical device to help chronic sinusitis sufferers worldwide
New medical device to help chronic sinusitis sufferers worldwide…
January 12, 2016
AFT Pharmaceuticals IPO Confirmed
AFT Pharmaceuticals IPO Confirmed and Product Disclosure Statement Lodged…
December 29, 2015
NZX Interim Announcement
The NZX Interim Announcement to 30 September 2015 is now available to view via the following link. The PDF will download automatically….
December 29, 2015
Access to AFT FY16 Interim Report
[assets/Uploads/151229-AFT-FY16-Interim-Report.pdf]Interim Report to 30 September 2015 is now available to view via the following link:…
November 19, 2015
Congratulations to the winner of our Maxigesic promotion with Ingenuity Dental
Congratulations Dr. Chris Burton of Noosa Dental Solutions, the lucky winner of our recent Maxigesic trade promotion in conjunction with Ingenuity Den…
November 9, 2015
Further test results available from Woolcock Institute, Sydney
Professor Paul M Young; Head of Respiratory Technology at the Woolcock Institute of Medical Research and Professor in Respiratory Technology at the Sc…
November 9, 2015
Stock Notification: Sandomigran, pizotifen 0.5 mg (as maleate) tablet
*Sandomigran, pizotifen 0.5 mg (as maleate) tablet AUST R69608*…
October 13, 2015
Ferro Pharmacy Promotion Winners Announced
Congratulations to the winners of our Ferro product promotion, which gave Pharmacists nationwide the chance to win $500 drawn weekly over 5 weeks and …
June 2, 2015
Further US investment in AFT Pharmaceuticals to advance international growth
Specialty Australasian pharmaceutical sales and development company, AFT Pharmaceuticals Ltd (AFT), has finalised a follow-on equity capital raise wit…
May 22, 2015
AFT Pharmaceuticals Expands Australian Presence
AFT Pharmaceuticals has increased its Australian presence with its own dedicated sales team of representatives visiting doctors and pharmacists….
May 22, 2015
AFT Group Sales Growth continues at +40%
Growth of 40% per annum continues for AFT Pharmaceuticals in the Australasian market (Australia and NZ) with sales for this year due to break $22 mill…
May 22, 2015
AFT targets $15 billion pain relief market
AFT Pharmaceuticals, a 100 per cent New Zealand owned company, has researched and developed a novel therapy which represents a breakthrough in pain re…
May 22, 2015
Australiasian drug company challenges industry to go Pseudoephedrine free
Homegrown pharmaceutical company challenges industry to go P-free…
May 22, 2015
New Zealand's world-first combination analgesic
AFT Pharmaceuticals has released Maxigesic®, a new analgesic tablet which for the first time in NZ combines Paracetamol and the anti-inflammatory Ibu…
May 22, 2015
Codeine a conundrum for kiwi consumers
A survey has found about a quarter (24 per cent) of New Zealanders who used an over-the-counter painkiller in the past three months took one which con…
May 22, 2015
PBS listing – Ferro-Tabs
AFT Pharmaceuticals is pleased to announce that from 01 September 2011 it's iron replacement product Ferro-Tabs will be PBS Listed….
May 22, 2015
Phenoxymethylpenicillin-AFT (Penicillin V) now in Australia
In Australia, AFT Pharmaceuticals is delighted to achieve further PBS listings, Phenoxymethylpenicillin-AFT (Penicillin V) Oral Liquid 125mg/5ml &…
May 22, 2015
AFT picks up Supreme Business award
A Takapuna-based drug company claimed top honours at the 2011 Westpac Auckland North Business Awards at the competition's annual Gala Dinner held…
May 22, 2015
AFT Pharmaceuticals establishes Orphan Drug Foundation
AFT Pharmaceuticals has commenced an orphan drug company with operations in Auckland, New Zealand; Sydney, Australia and Kuala Lumpur, Malaysia to eff…
May 22, 2015
AFT Pharmaceuticals expands operations to South East Asia
The AFT Pharma group is delighted to expand its operations to South East Asia with the establishment of a regional office in Kuala Lumpur….
May 22, 2015
New VitA-Pos Eye Ointment Introduced for night time use
AFT Pharmaceuticals is pleased to announce the launch of the new VitA-POS® eye ointment to the Australian market….
May 22, 2015
AFT introduces new HYLO-FRESH and HYLO-FORTE
AFT Pharmaceuticals is pleased to announce the launch of new HYLO®-FRESH and HYLO- FORTE® eye drops to the Australian market….
May 22, 2015
AFT Pharmaceutical awarded R&D grant by Callaghan Innovation
AFT Pharmaceuticals has today been announced as a recipient of a government Technology Development Grant (TDG) by Callaghan Innovation….
May 22, 2015
Femme-Tab ED 20/100 is the first low oestrogen contraceptive pill added to PBS schedule in Australia
The Pharmaceutical Benefits Scheme (Australia) has added a low oestrogen dose combined oral contraceptive (COC) pill for the first time to its schedul…
May 22, 2015
EY Entrepreneur of the Year awards
The founder of AFT Pharmaceuticals, Hartley Atkinson, has been chosen as one of 18 finalists in the EY Entrepreneur of the Year awards….
May 22, 2015
Maxigesic Pain Relief now available in Australia
Launched this month, MAXIGESIC® is the first analgesic that combines both Paracetamol and Ibuprofen to be registered for use in Australia….
May 22, 2015
Australasian company finds major formulation error with cold and flu products
AFT Pharmaceuticals has identified a major error with the formulation of over 1,300 cold and flu products used around the world….
May 22, 2015
New York Times: Some cold medicines may have higher than expected levels of a decongestant
Some widely used over-the-counter cold and flu medicines may be exposing patients to unexpectedly high amounts of one ingredient, revealing a lapse in…
May 22, 2015
Views of New Zealand self-medication body at odds with safety concerns of some members
AFT Pharmaceuticals (AFT) has identified a major error with the formulation of over 1300 cold and flu products used around the world….
May 22, 2015
AFT Pharmaceuticals closes important financing to spur global growth
Innovative Australasian pharmaceutical sales and development company, AFT Pharmaceuticals Ltd has finalised an equity and structured debt funding pack…
May 22, 2015
TIN 100: AFT Pharmaceuticals on the rise
AFT Pharmaceuticals has entered the "top 10" to watch list for the first time, with $14.9 million growth in revenues in 2014….
May 22, 2015
New Zealand Herald Profile: AFT Pharmaceuticals
While starting a company with just $50,000, from your garage, may seem a typically Kiwi thing to do, it is much less often that it results in a multi-…
May 5, 2015
Doctors have alternatives to topical antibitoc treatments
Some text…
May 5, 2015
NZ pharmacists concerned about codeine-based analgesics
Some text…
May 5, 2015
Many Australian pharmacists have concerns about OTC codeine-based analgesics
Some text…
May 5, 2015
Martindale announces AFT as distribution partner for Asia Pacific
Martindale announces AFT as distribution partner for Asia Pacific…
May 5, 2015
Impressive clinical trial results for Maxigesic
AFT Pharmaceuticals has now concluded a pivotal clinical study of 408 patients in the US and NZ. The study will form the basis of AFT's first fil…
May 5, 2015
Maxigesic wins best new product award in Australia
This month Maxigesic picked up the the 'Best New Product' award at the 2014 National Convention and Exhibition of the Pharmacy Guild….
October 28, 2009
Kiwi Co. pops pill into US$20b pain-relief market
New Zealanders will find a home-grown answer to pain relief on the shelves at their local pharmacy this month with the launch of a new drug that repre…